Clinical & translational oncology

• 

  Año 2024, Vol. 26, Número 6

  • Neoplastic appendiceal mucinous lesions: a narrative review of the literature from an oncologist’s perspective

    Carlos Ayala de Miguel, Jerónimo Jiménez Castro, Adrián Sánchez Vegas, Sebastián Díaz López, Manuel Chaves Conde

    • Resumen

    págs. 1287-1299

    

  • CAR‑T cell therapy: a game‑changer in cancer treatment and beyond

    Kumar Utkarsh, Namita Srivastava, Sachin Kumar, Azhar Z. Khan, Gunjan Dagar, Mayank Singh, Mukesh Kumar, Shabirul Haque

    • Resumen

    págs. 1300-1318

    

  • Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer‑associated thrombosis patients’ healthcare in Spain

    Andrés Jesús Muñoz Martín, A. Javier Trujillo-Santos, Edelmira Martí Sáez, Luis Jara Palomares, Pedro Ruiz Artacho, Raquel Macias Montero, Enrique Gallardo-Díaz, Juan J. López Núñez, Elena Brozos Vázquez, Verónica Robles, Pedro Pérez Segura

    • Resumen

    págs. 1319-1328

    

  • Comparing the survival rates of patients with stage IIIC endometrial cancer undergoing sandwich therapy to those undergoing sequential chemotherapy and radiotherapy: a meta‑analysis

    Meng Meng Zhang, Yu Kun Chen, Li Shi, Jing Ma, Jing Jia, Xi Zhao

    • Resumen

    págs. 1329-1337

    

  • High‑grade transformation of head and neck adenoid cystic carcinoma demonstrates distinctive clinicopathological features and an unfavorable prognosis: a matched case‑control study of the largest series in China

    Ting yao Ma, Jun Wu, Shi zhi He, Xue-Lian Wang, Guo liang Yang, Shu jing Zhang, Jin Zhou, Yi ming Ding, Li feng Li, Hong fei Liu, Lan lan Xuan, Xiao hong Chen

    • Resumen

    págs. 1338-1347

    

  • Cardiovascular comorbidities and their prognostic value in small cell lung cancer patients with chemoradiotherapy

    Hanyang Liang, Tianjie Wang, Dong Liu, Hao Wang, Zhengqing Ba, Ying Xiao, Yilu Liu, Jiansong Yuan, Weixian Yang

    • Resumen

    págs. 1348-1356

    

  • Continuation of immunotherapy beyond progression is benefcial to the survival of advanced non‑small‑cell lung cancer

    Siqi Song, Xiaobo Ding, Chuchu Lin, Bin Wang, Wenfeng Li, Yuanyuan Cheng, Chunhong Zhang, Zhe Ye, Yanru Xie, Xuedan Du

    • Resumen

    págs. 1357-1367

    

  • A novel prognostic model for predicting patient survival and immunotherapy responsiveness in hepatocellular carcinoma: Insights into the involvement of T‑cell proliferation

    Shengjie Tang, Kechao Tang, Xiang Wei, Ming Liu, Huabing Zhang, Rui Sun

    • Resumen

    págs. 1368-1383

    

  • Identifcation of non‑actionable mutations with prognostic and predictive value in patients with advanced or metastatic non‑small cell lung cancer

    Mariano Provencio Pulla, Diego Pérez Parente, Sara Olson, Pedro Ruiz Gracia, Esther Vilas, Haroon Hasan, Navdeep Pal, Begoña Campos Balea, Delvys Rodríguez Abreu, Marta López-Brea, Samantha Wilkinson, Manuel Cobo Dols

    • Resumen

    págs. 1384-1394

    

  • Primary versus acquired epidermal growth factor receptor Thr790Met mutant non‑small cell lung cancer: clinical features and prognoses

    Mengying Li, Xiaohan Wang, Siqi Zhou, Guoxin Cai, Ying Fu, Xue Meng, Xiao Han, Kaiyue Wang

    • Resumen

    págs. 1395-1406

    

  • Depression promotes breast cancer progression by regulating amino acid neurotransmitter metabolism and gut microbial disturbance

    Sisi Lin, Zhe Zhou, Yiming Qi, Jiabing Chen, Guoshu Xu, Yunfu Shi, Zhihong Yu, Kequn Chai, Mingqian Li

    • Resumen

    págs. 1407-1418

    

  • Radiation‑induced changes in gene expression in rectal cancer specimens

    Lily Victoria Sarah Hillson, Ashley Kathryn McCulloch, Joanne Edwards, Sean Michael OCathail, Campbell Stuart Roxburgh, Philip David Dunne

    • Resumen

    págs. 1419-1428

    

  • Delphi consensus for the third‑line treatment of metastatic colorectal cancer

    Pilar García Alfonso, Ruth Vera García, Enrique Aranda Aguilar, Elena Élez Fernández, Fernando Rivera Herrero

    • Resumen

    págs. 1429-1437

    

  • Using Vision Transformer for high robustness and generalization in predicting EGFR mutation status in lung adenocarcinoma

    Luoqi Weng, Yuan Chen, Chengshui Chen, Yilun Xu, Qingqing Qian, Jie Pan, Huang Su

    • Resumen

    págs. 1438-1445

    

  • Tumor mutational burden as a predictive biomarker for non‑small cell lung cancer treated with immune checkpoint inhibitors of PD‑1/PD‑L1

    Min min Shao, Yue ping Xu, Jing-Jing Zhang, Mao Mao, Meng Wang

    • Resumen

    págs. 1446-1458

    

  • Efects of Doxorubicin, Epirubicin, and Liposomal Doxorubicin (Anthracycline) on cardiac function in patients with osteosarcoma and their infuencing factors

    Shanshan Ding, Shasha Xiong, Xueli Wang, Changdong Zhang, Song Chen, Ming Sun, Chunlin Wu, Xing Zhang, Meiying Wang, Jia Wang Ding, Xiaoke Shang

    • Resumen

    págs. 1459-1466

    

  • The predictive value of systemic immune‑infammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients

    Huibo Wang, Zhenfeng Huang, Bingqi Xu, Jinxing Zhang, Pengfei He, Fei Gao, Ruifeng Zhang, Xiatian Huang, Ming Shan

    • Resumen

    págs. 1467-1479

    

  • Changes in the fecal microbiota of breast cancer patients based on 16s rrna gene sequencing: a systematic review and meta‑analysis

    Biqing Luan, Fei Ge, Xingjia Lu, Zhiqiang Li, Hong Zhang, Jingxuan Wu, Qizhi Yang, Liang Chen, Wenzhu Zhang, Wenlin Chen

    • Resumen

    págs. 1480-1496

    

  • Exosomal noncoding RNAs as noninvasive biomarkers in bladder cancer: a diagnostic meta‑analysis

    Liming Zhao, Jun Li, Zhongguang Xue, Jinfeng Wang

    • Resumen

    págs. 1497-1507

    

  • Impact of anthracycline‑based chemotherapy on RB1 gene methylation in peripheral blood leukocytes and biomarkers of oxidative stress and infammation in sarcoma patients

    Anita Pokupec Bilić, Morana Mikloš, Ivana Tonković Đurišević, Ivan Bilić, Luka Simetić, Krešimir Blažičević, Davorin Herceg, Sandra Radić Brkanac, Ana Marija Domijan

    • Resumen

    págs. 1508-1518

    

  • Clinical signifcance and prospective mechanism of increased CDKN2A expression in small cell lung cancer

    Dong Ming Li, Wan Ying Huang, Zhi Guang Huang, Jian Di Li, Yi Wu Dang, Yu Lu Tang, Wen Tang, Gang Chen, Hui Ping Lu, Guo Sheng Li, Feng Chen, Hong Huang, Zhong Qing Tang

    • Resumen

    págs. 1519-1531

    

  • Exploratory analyses of treatment subgroup interaction by PD‑L1 status and according to PD‑L1 expression in the JAVELIN Bladder 100 trial

    Miguel Ángel Climent Durán, Carlos Álvarez Laso, Rafael Morales Barrera, Pablo Maroto Rey, Alejo Rodriguez Vida, María José Méndez Vidal, Xavier García del Muro, Javier Puente Vázquez, Nuria Láinez Milagro, Sergio Vázquez Estévez, Daniel Castellano-Gauna, Carmen Gómez Lang, Jing Wang, Alessandra di Pietro, Craig Davis, Belén Sanz Castillo, Victoria Bolós Fernández, B. Pérez Valderrama

    • Resumen

    págs. 1532-1538